De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
Summary: Lasso-grafting (LG) technology is a method for generating de novo biologics (neobiologics) by genetically implanting macrocyclic peptide pharmacophores, which are selected in vitro against a protein of interest, into loops of arbitrary protein scaffolds. In this study, we have generated a n...
Guardado en:
Autores principales: | Yamato Komatsu, Naohiro Terasaka, Katsuya Sakai, Emiko Mihara, Risa Wakabayashi, Kunio Matsumoto, Donald Hilvert, Junichi Takagi, Hiroaki Suga |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f66388c0f64b4cedba1f72a4ac812d78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins
por: Emiko Mihara, et al.
Publicado: (2021) - Synthetic biology
-
A Critical Analysis of the Scientific and Commercial Rationales for the <italic toggle="yes">De Novo</italic> Synthesis of Horsepox Virus
por: Gregory D. Koblentz
Publicado: (2018) -
Build-a-Cell: Engineering a Synthetic Cell Community
por: Caroline Frischmon, et al.
Publicado: (2021) -
A New Method of Repairing Giant Omphaloceles with Bilateral Mesh Grafts Lateral to the Rectus Abdominis Muscles
por: Hamidreza Foroutan, et al.
Publicado: (2013)